Human Genome Sciences is the word on StockTwits and @stockguy22 is the prophet. HGSI closed up 276% from Friday’s close on news of a promising lupus treatment called Benlysta. The stock is technically strong and may continue to be profitable, but it is so extended from its base that it is hard to quantify a…